Report Scope & Overview:
The Real-Time PCR (qPCR) Market Size was valued at USD 5.2 billion in 2022 and expected to reach USD 8.07 billion by 2030, and grow at a CAGR of 5.65% over the forecast period 2023-2030.
The Real-Time PCR (qPCR) test detects nucleic acid from a patient's samples who has Severe Acute Respiratory Syndrome Coronavirus 2. (SARS CoV-2). Rising demand for real-time PCR (qPCR) for the treatment of the current COVID-19 outbreak, as well as technological improvements, have enabled healthcare providers to detect infection levels in real-time. This is one of the primary factors driving the growth of the real-time PCR (qPCR) industry. However, there are risks in the Real-Time PCR (qPCR) sector, such as difficult regulatory scenarios, high costs, the potential of eliciting false negative and positive results, and the inability of emerging nations to fund research.
To get more information on Real-Time PCR (qPCR) Market - Request Sample Report
Rising demand for Real-Time PCR as a result of the COVID-19 epidemic
The increase in COVID-19 pandemic has sparked interest in real-time PCR for quick diagnosis.
Pharmaceutical firms are involved in R&D and collaborate with other biotechnology firms.
The possibility of obtaining false-negative and false-positive results
Among the various technological advances in the medical business, nucleic acid detection-based techniques have emerged as a fast and reliable technology for viral identification.
The qualitative PCR approach is regarded the "gold standard" for virus identification because of its great sensitivity, quick detection, and specificity.
IMPACT OF COVID-19:
The increased prevalence of COVID-19 is expected to have a positive impact on the real-time PCR (qPCR) market growth throughout the forecast period. The demand for effective and rapid testing is increasing as the coronavirus outbreak grows, intensifying the COVID-19 pandemic. The real-time PCR (qPCR) kit is regarded as one of the most in-demand procedures in the healthcare business, resulting in a spike in demand for these kits. This feature is expected to have a favourable impact on the growth of the real-time PCR (qPCR) market, which in turn will aid in driving the growth of the real-time PCR (qPCR) market.
Many research institutions and universities are providing excellent assistance by providing real-time PCR (qPCR) platforms for doing various tests, which is one of the most accurate laboratory methods for detecting, tracking, and researching the COVID-19 virus. Furthermore, government actions supporting approved real-time PCR (qPCR) kits to aid in the diagnosis of COVID-19 are a positive element. The Indian government, for example, has approved 12 fast antibody test kits for COVID-19 diagnosis. The Indian Council of Medical Research (ICMR) has also released recommendations for COVID-19 fast antibody test kits.
Template cDNA, Upstream and downstream primers, GoTaq DNA Polymerase with reaction buffer, dNTP mixture, Molecular grade, nuclease-free water, and Agarose are the various reagents and tests used for real-time PCR. The increasing use of reagents and tests such as TaqMan Real-time PCR assays is likely to drive the market in this sector over the study period.
Plastics and supplies for qPCR studies, such as tubes, plates, caps, adhesive plate seals, strips, and racks, are examples of real-time consumables. They have been validated for maximum performance with real-time PCR systems. The increasing use of these real-time PCR consumables to perform various molecular operations in real-time PCR systems is supporting the expansion of this segment's real-time PCR (qPCR) market.
Rising efforts by PCR manufacturers to create novel real-time PCR instrument systems and kits for molecular testing are expected to drive expansion in the real-timePCR (qPCR) market. Furthermore, when compared to current digital PCR systems, the new technology provides highly automated operations and faster turnaround time, giving the organisation a substantial competitive edge.
The software and services for real-time PCR (qPCR) assist customers in making sensible and strong data analysis decisions. These applications are intended to simplify the gathering and analysis of real-time PCR data. The increasing use of these software for accurate experiment results and molecular procedures is propelling the real-time PCR (qPCR) market growth of this segment.
The growing number of acute and chronic disorders that necessitate molecular testing is driving the real-time PCR market forward. Furthermore, technological advances in molecular assays and procedures, as well as the shown efficacy of real-time PCR (qPCR) analysis in diagnosis, have increased the use of clinical diagnostic testing (including qPCR analysis). This segment's growth is being aided by these factors. The increasing use of real-time PCR techniques in drug development and research activities is driving the growth of the real-time PCR (qPCR) market in this segment. Increased R&D spending by many biotechnology and pharmaceutical businesses is another important element driving market expansion.
DNA profiling is a technique used by forensic investigators to identify individuals based on their DNA profiles. Real-time PCR can be used to identify DNA fingerprints. This technology can identify any person among millions, which is expected to boost the growth of the real-time PCR market in this category. As a result, the increasing use of real-time PCR for DNA fingerprinting is propelling the real-time PCR market expansion of this category.
Other real-time market applications include the food and beverage (F&B) and agriculture industries. Real-time polymer chain reaction is an important analytical tool in both food and medical diagnostics. The increasing use of real-time in the food and beverage and agriculture industries to quantify crops is driving the real-time PCR market expansion in this segment.
The hospitals and diagnostic centres segment dominated the real-time PCR (qPCR) market as a result of the ongoing expansion of healthcare infrastructure across emerging countries; increasing market availability of qPCR reagents and instruments in various clinical diagnostic applications; high prevalence and incidence of target diseases such as HIV-AIDS, malaria, cancer, and tuberculosis; and rising awareness among end users about the various benefits offered by real-time (qPCR) I
In many research laboratories and academic institutions, qPCR and dPCR technologies are used.
The popularity of these systems can be ascribed to aspects such as increased specificity and short turnaround time. This element, in turn, contributes to the growth of the real-time PCR (qPCR) market in this category.
Furthermore, the increasing use of real-time PCR (qPCR) instrument systems in drug development will drive real-time PCR (qPCR) market growth for real-time PCR (qPCR) products in the biotechnology and pharmaceutical industries, which will also drive real-time PCR (qPCR) market growth during the study period.
Real-time PCR (qPCR) is critical for drug research development since it allows for the identification and quantification of numerous diseases, and it is widely utilised in many pharmaceutical and biotechnology businesses. This element is playing an important role in the expansion of this segment.
The use of real-time PCR for a variety of therapeutic applications has grown significantly in many clinical research organizations.
The rising number of qPCR assays being developed in single and multiplex modes by forensic laboratories for measuring DNA in forensic material is propelling the industry. These assays are designed to improve the accuracy and precision of DNA quantifications while also providing tools to increase the efficiency and throughput of forensic sample analysis.
Value Chain Analysis
The global real-time PCR market is expanding steadily as a result of the increasing number of market participants engaging in new product launches, acquisitions, and strategic collaborations. The value chain analysis of the real-time PCR market includes four primary components, beginning with R&D and design and continuing with product manufacturing, distribution and sales, and post-sales services.
Real-time PCR R&D design begins with conceptualization, then moves on to design, development, and testing. The R&D segment accounts for 25-30% of the value chain of real-time PCR. After the product designs are finalized, the production process begins. Manufacturing accounts for 35-40% of the value chain of real-time PCR.
KEY MARKET SEGMENTS:
By End User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Reagents & Consumables
Software & Services
Need any customization research on Real-Time PCR (qPCR) Market - Enquiry Now
North America continues to be the most profitable region, accounting for over 57% of the worldwide real-time PCR (qPCR) market. Increased use of unique and creative genetic analysis products, as well as the availability of R&D funds, are factors leading to North America's supremacy in this market arena.
The high prevalence of chronic and infectious diseases, together with increased patient awareness regarding early diagnosis of these diseases, is expected to enhance demand for PCR products in Asia Pacific, propelling the region's market expansion in the next years.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Major players are BD, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, QIAGEN, ABL SA Group, Agilent Technologies, Inc., Analytik Jena AG, Fluidigm Corporation, Lumex Instruments, Primerdesign Ltd. and Other Players.
Fluidigm Corporation-Company Financial Analysis
|Market Size in 2022||US$ 5.2 Bn|
|Market Size by 2030||US$ 8.07 Bn|
|CAGR||CAGR of 5.65% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Application (Clinical, Research, and Forensics)
• By End User (Hospitals &Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, and Forensic Laboratories)
• By Product (Reagents & Consumables, Instruments, Software & Services)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||BD, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, QIAGEN, ABL SA Group, Agilent Technologies, Inc., Analytik Jena AG, Fluidigm Corporation, Lumex Instruments, Primerdesign Ltd.|
|Key Drivers||• Rising demand for Real-Time PCR as a result of the COVID-19 epidemic
• The increase in COVID-19 pandemic has sparked interest in real-time PCR for quick diagnosis.
|Market Opportunities||• The qualitative PCR approach is regarded the "gold standard" for virus identification because of its great sensitivity, quick detection, and specificity.|
Ans: The Real-Time PCR (qPCR) Market Size was valued at USD 5.2 billion in 2022.
Ans: The Real-Time PCR (qPCR) Market is to grow at a CAGR of 5.65% over the forecast period 2023-2030.
Ans: The Real-Time PCR (qPCR) test detects nucleic acid from a patient's samples who has Severe Acute Respiratory Syndrome Coronavirus 2. (SARS CoV-2).
Rising demand for Real-Time PCR as a result of the COVID-19 epidemic
The increase in COVID-19 pandemic has sparked interest in real-time PCR for quick diagnosis.
Ans: The possibility of obtaining false-negative and false-positive results
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Real-Time PCR Market, by Application
9. Real-Time PCR Market, by End User
9.1 Hospitals &Diagnostic Centers
9.2 Research Laboratories & Academic Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Clinical Research Organizations
9.5 Forensic Laboratories
10. Real-Time PCR Market, by Product
10.1 Reagents & Consumables
10.3 Software & Services
11. Regional Analysis
11.2 North America
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4.2 South Korea
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.3 South Africa
11.6 Latin America
11.6.3 Rest of Latin America
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Bio-Rad Laboratories, Inc.
12.3 Hoffmann-La Roche Ltd
12.5 ABL SA Group
12.6 Agilent Technologies, Inc.
12.7 Analytik Jena AG
12.8 Fluidigm Corporation
12.9 Lumex Instruments
12.10 Primerdesign Ltd.
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Clinical Chemistry Analyzer Market size was estimated USD 12.8 billion in 2022 and is expected to reach USD 19.05 billion by 2030 at a CAGR of 5.1% during the forecast period of 2023-2030.
The Corporate Wellness Market Size was valued at USD 61.11 billion in 2022 and is projected to reach USD 109.81 billion in 2030, with a growing of CAGR of 7.6% during the forecast period 2023-2030.
The Protein Purification and Isolation Market size was estimated USD 8.5 billion in 2022 and is expected to reach USD 19.1 billion by 2030 at a CAGR of 10.7%during the forecast period of 2023-2030.
The Healthcare Education Market Size was valued at USD 98.58 billion in 2022, and is expected to reach USD 190.74 billion by 2030 and grow at a CAGR of 8.6% over the forecast period 2023-2030.
The mRNA Therapeutics Market size was valued at USD 39.40 billion in 2022 and is expected to grow at USD 45.40 billion by 2030, and grow at a CAGR of 1.5 % over the forecast period of 2023-2030.
In 2022, The Telerehabilitation Market size amounted to USD 3.70 Billion & is estimated to reach USD 11.39 Billion by 2030 and increase at a compound annual growth rate of 15.1% between 2023 and 2030.
Hi! Click one of our member below to chat on Phone